Table 1 Summary of baseline characteristics of the ITT population
| Â | Ezetimibe (N = 29) | Statin (N = 34) | P-value |
|---|---|---|---|
Age, mean (SD) | 54.2 (10.9) | 61.2 (10.5) | 0.0277* |
Height, mean (SD) | 164.0 (10.3) | 159.5 (9.2) | 0.5549* |
Weight, mean (SD) | 75.0 (15.7) | 71.0 (11.2) | 0.0733* |
Sex | Â | Â | Â |
Male, n (%) | 17 (58.6) | 18 (52.9) | 0.7999†|
Female, n (%) | 12 (41.4) | 16 (47.1) | --- |
Diabetes Mellitus, n (%) | 14 (48.3) | 16 (47.1) | 0.9304* |
Hypertension, n (%) | 10 (34.5) | 27 (79.4) | 0.0007* |
Coronary Artery Disease, n (%) | 8 (27.6) | 10 (29.4) | 0.8814* |
Total cholesterol, mean (SD) | 213.6 (48.4) | 207.3 (28.8) | 0.8577* |
LDL-C, mean (SD) | 144.6 (45.8) | 130.9 (19.4) | 0.2119* |
HDL-C, mean (SD) | 48.4 (9.1) | 52.5 (11.9) | 0.1047* |
Triglycerides, mean (SD) | 140.3 (59.7) | 158.5 (68.1) | 0.3107* |
ALT, mean (SD) | 30.7 (12.6) | 26.9 (8.1) | 0.2381* |
AST, mean (SD) | 25.5 (7.7) | 25.2 (7.8) | 0.3761* |
CK, mean (SD) | 121. 5 (64.0) | 108.0 (77.1) | 0.1924* |
GGT, mean (SD) | 31.8 (16.5)‡ | 44.3 (32.0) | 0.1318* |